Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI).
The 13th annual ADMET conference is returning to London, UK for an in-depth exploration of the optimisation of ADMET modelling techniques, preclinical DMPK applications and the development of bioph
BenevolentAI and a group of UK sight loss charities have launched a new partnership to use the firm’s AI-powered drug discovery to find treatments and a potential cure for age-related macul